Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.08 - $0.55 $30,768 - $211,530
384,600 Added 55.34%
1,079,515 $93,000
Q2 2023

Aug 11, 2023

SELL
$0.56 - $1.17 $1,400 - $2,925
-2,500 Reduced 0.36%
694,915 $389,000
Q1 2023

May 12, 2023

SELL
$1.02 - $1.39 $18,156 - $24,742
-17,800 Reduced 2.49%
697,415 $795,000
Q4 2022

Feb 13, 2023

SELL
$1.02 - $1.61 $57,927 - $91,435
-56,792 Reduced 7.36%
715,215 $801,000
Q3 2022

Nov 14, 2022

SELL
$1.28 - $2.91 $87,680 - $199,335
-68,500 Reduced 8.15%
772,007 $1.62 Million
Q2 2022

Aug 12, 2022

SELL
$1.21 - $1.81 $176,921 - $264,650
-146,216 Reduced 14.82%
840,507 $1.14 Million
Q1 2022

May 13, 2022

SELL
$1.03 - $2.01 $380,122 - $741,792
-369,051 Reduced 27.22%
986,723 $1.67 Million
Q4 2021

Feb 11, 2022

BUY
$0.98 - $3.06 $429,950 - $1.34 Million
438,725 Added 47.84%
1,355,774 $1.46 Million
Q3 2021

Nov 12, 2021

SELL
$2.79 - $4.19 $156,387 - $234,862
-56,053 Reduced 5.76%
917,049 $2.71 Million
Q2 2021

Aug 13, 2021

BUY
$2.8 - $3.78 $18,466 - $24,929
6,595 Added 0.68%
973,102 $2.93 Million
Q1 2021

May 13, 2021

SELL
$3.26 - $4.84 $184,842 - $274,428
-56,700 Reduced 5.54%
966,507 $3.15 Million
Q4 2020

Feb 10, 2021

BUY
$4.12 - $6.29 $119,480 - $182,410
29,000 Added 2.92%
1,023,207 $4.22 Million
Q3 2020

Nov 13, 2020

BUY
$4.82 - $8.77 $206,778 - $376,233
42,900 Added 4.51%
994,207 $5.38 Million
Q2 2020

Aug 13, 2020

SELL
$2.83 - $6.99 $202,062 - $499,086
-71,400 Reduced 6.98%
951,307 $6.4 Million
Q1 2020

May 14, 2020

BUY
$3.18 - $7.0 $1.63 Million - $3.59 Million
512,595 Added 100.49%
1,022,707 $3.25 Million
Q4 2019

Feb 13, 2020

BUY
$3.46 - $7.7 $1.31 Million - $2.92 Million
379,300 Added 289.96%
510,112 $3.57 Million
Q3 2019

Nov 13, 2019

BUY
$2.8 - $3.99 $264,320 - $376,656
94,400 Added 259.26%
130,812 $502,000
Q2 2019

Aug 12, 2019

BUY
$2.34 - $4.28 $85,204 - $155,843
36,412 New
36,412 $138,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.